These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 2439800

  • 1. Cardiac and vascular beta-adrenoceptor-mediated responses before and during treatment with bisoprolol or atenolol.
    Bolli P, Müller FB, Linder L, Ji BH, Bühler FR.
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S61-4. PubMed ID: 2439800
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A dose-ranging study to evaluate the beta 1-adrenoceptor selectivity of bisoprolol.
    Lipworth BJ, Irvine NA, McDevitt DG.
    Eur J Clin Pharmacol; 1991; 40(2):135-9. PubMed ID: 1676675
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Pringle TH, O'Connor PC, McNeill AJ, Finch MB, Riddell JG, Shanks RG.
    Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
    [Abstract] [Full Text] [Related]

  • 7. The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics.
    Chatterjee SS.
    J Cardiovasc Pharmacol; 1986 Mar; 8 Suppl 11():S74-7. PubMed ID: 2439803
    [Abstract] [Full Text] [Related]

  • 8. Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses.
    Riddell JG, Shanks RG.
    Clin Pharmacol Ther; 1985 Nov; 38(5):554-9. PubMed ID: 2865028
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The assessment of the beta-adrenoceptor blocking activity and cardioselectivity of Koe 3290 in normal subjects.
    Pringle TH, McNeill AJ, Riddell JG, Shanks RG.
    Br J Clin Pharmacol; 1987 Nov; 24(5):581-9. PubMed ID: 2893635
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Beta 1-selectivity of bisoprolol, a new beta-adrenoceptor antagonist, in anesthetized dogs and guinea pigs.
    Schliep HJ, Harting J.
    J Cardiovasc Pharmacol; 1984 Nov; 6(6):1156-60. PubMed ID: 6084774
    [Abstract] [Full Text] [Related]

  • 18. Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade.
    Hansen O, Johansson BW, Nilsson-Ehle P.
    Angiology; 1990 Mar; 41(3):175-88. PubMed ID: 1968731
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A randomized double-blind study of bisoprolol versus atenolol in mild to moderate essential hypertension.
    Dixon MS, Thomas P, Sheridan DJ.
    Eur J Clin Pharmacol; 1990 Mar; 38(1):21-4. PubMed ID: 1970298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.